|
1
|
Hsiao KY, Sun HS and Tsai SJ: Circular RNA-new member of noncoding RNA with novel functions. Exp Biol Med (Maywood). 242:1136–1141. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lei B, Tian Z, Fan W and Ni B: Circular RNA: A novel biomarker and therapeutic target for human cancers. Int J Med Sci. 16:292–301. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sanger HL, Klotz G, Riesner D, Gross HJ and Kleinschmidt AK: Viroids are single-stranded covalently closed circular RNA molecules existing as highly base-paired rod-like structures. Proc Natl Acad Sci USA. 73:3852–3856. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Salzman J, Chen RE, Olsen MN, Wang PL and Brown PO: Cell-type specific features of circular RNA expression. PLoS Genet. 9:e10037772013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Afonina ZA, Myasnikov AG, Shirokov VA, Klaholz BP and Spirin AS: Formation of circular polyribosomes on eukaryotic mRNA without cap-structure and poly(A)-tail: A cryo electron tomography study. Nucleic Acids Res. 42:9461–9469. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shen T, Han M, Wei G and Ni T: An intriguing RNA species-perspectives of circularized RNA. Protein Cell. 6:871–880. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang Y, Mo Y, Gong Z, Yang X, Yang M, Zhang S, Xiong F, Xiang B, Zhou M, Liao Q, et al: Circular RNAs in human cancer. Mol Cancer. 16:252017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu J, Liu T, Wang X and He A: Circles reshaping the RNA world: From waste to treasure. Mol Cancer. 16:582017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bramham CR and Wells DG: Dendritic mRNA: Transport, translation and function. Nat Rev Neurosci. 8:776–789. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Burd CE, Jeck WR, Liu Y, Sanoff HK, Wang Z and Sharpless NE: Expression of linear and novel circular forms of an INK4/ARF-associated non-coding RNA correlates with atherosclerosis risk. PLoS Genet. 6:e10012332010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Abdelmohsen K, Panda AC, De S, Grammatikakis I, Kim J, Ding J, Noh JH, Kim KM, Mattison JA, de Cabo R and Gorospe M: Circular RNAs in monkey muscle: Age-dependent changes. Aging (Albany NY). 7:903–910. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xu H, Guo S, Li W and Yu P: The circular RNA Cdr1as, via miR-7 and its targets, regulates insulin transcription and secretion in islet cells. Sci Rep. 5:124532015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
de Fraipont F, Gazzeri S, Cho WC and Eymin B: Circular RNAs and RNA splice variants as biomarkers for prognosis and therapeutic response in the liquid biopsies of lung cancer patients. Front Genet. 10:3902019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rao M, Zhu Y, Qi L, Hu F and Gao P: Circular RNA profiling in plasma exosomes from patients with gastric cancer. Oncol Lett. 20:2199–2208. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shen T, Cheng X, Liu X, Xia C, Zhang H, Pan D, Zhang X and Li Y: Circ_0026344 restrains metastasis of human colorectal cancer cells via miR-183. Artif Cells Nanomed Biotechnol. 47:4038–4045. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Qiu L, Wang T, Ge Q, Xu H, Wu Y, Tang Q and Chen K: Circular RNA signature in hepatocellular carcinoma. J Cancer. 10:3361–3372. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kristensen LS, Hansen TB, Venø MT and Kjems J: Circular RNAs in cancer: Opportunities and challenges in the field. Oncogene. 37:555–565. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Memczak S, Jens M, Elefsinioti A, Torti F, Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer M, et al: Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 495:333–338. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hsiao KY, Lin YC, Gupta SK, Chang N, Yen L, Sun HS and Tsai SJ: Noncoding effects of circular RNA CCDC66 promote colon cancer growth and metastasis. Cancer Res. 77:2339–2350. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Qu S, Liu Z, Yang X, Zhou J, Yu H, Zhang R and Li H: The emerging functions and roles of circular RNAs in cancer. Cancer Lett. 414:301–309. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang L, Tong X, Zhou Z, Wang S, Lei Z, Zhang T, Liu Z, Zeng Y, Li C, Zhao J, et al: Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by controlling TIF1γ in non-small cell lung cancer. Mol Cancer. 17:1402018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li Y, Wan B, Liu L, Zhou L and Zeng Q: Circular RNA circMTO1 suppresses bladder cancer metastasis by sponging miR-221 and inhibiting epithelial-to-mesenchymal transition. Biochem Biophys Res Commun. 508:991–996. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang Y, Xu R, Zhang D, Lu T, Yu W, Wo Y, Liu A, Sui T, Cui J, Qin Y, et al: Circ-ZKSCAN1 regulates FAM83A expression and inactivates MAPK signaling by targeting miR-330-5p to promote non-small cell lung cancer progression. Transl Lung Cancer Res. 8:862–875. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
De Luca A, Maiello MR, D'Alessio A, Pergameno M and Normanno N: The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: Role in cancer pathogenesis and implications for therapeutic approaches. Expert Opin Ther Targets. 16 (Suppl 2):S17–S27. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen T, Xiao Q, Wang X, Wang Z, Hu J, Zhang Z, Gong Z and Chen S: miR-16 regulates proliferation and invasion of lung cancer cells via the ERK/MAPK signaling pathway by targeted inhibition of MAPK kinase 1 (MEK1). J Int Med Res. 47:5194–5204. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Delire B and Stärkel P: The Ras/MAPK pathway and hepatocarcinoma: Pathogenesis and therapeutic implications. Eur J Clin Invest. 45:609–623. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shaw RJ and Cantley LC: Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature. 441:424–430. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Burotto M, Chiou VL, Lee JM and Kohn EC: The MAPK pathway across different malignancies: A new perspective. Cancer. 120:3446–3456. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Santarpia L, Lippman SM and El-Naggar AK: Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy. Expert Opin Ther Targets. 16:103–119. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fremin C and Meloche S: From basic research to clinical development of MEK1/2 inhibitors for cancer therapy. J Hematol Oncol. 3:82010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ichijo H, Nishida E, Irie K, ten Dijke P, Saitoh M, Moriguchi T, Takagi M, Matsumoto K, Miyazono K and Gotoh Y: Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science. 275:90–94. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu RM, Choi J, Wu JH, Gaston Pravia KA, Lewis KM, Brand JD, Mochel NS, Krzywanski DM, Lambeth JD, Hagood JS, et al: Oxidative modification of nuclear mitogen-activated protein kinase phosphatase 1 is involved in transforming growth factor beta1-induced expression of plasminogen activator inhibitor 1 in fibroblasts. J Biol Chem. 285:16239–16247. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Robinson KA, Stewart CA, Pye QN, Nguyen X, Kenney L, Salzman S, Floyd RA and Hensley K: Redox-sensitive protein phosphatase activity regulates the phosphorylation state of p38 protein kinase in primary astrocyte culture. J Neurosci Res. 55:724–732. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Maurer G, Tarkowski B and Baccarini M: Raf kinases in cancer-roles and therapeutic opportunities. Oncogene. 30:3477–3488. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ray PD, Huang BW and Tsuji Y: Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal. 24:981–990. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yang Z, Xie L, Han L, Qu X, Yang Y, Zhang Y, He Z, Wang Y and Li J: Circular RNAs: Regulators of cancer-related signaling pathways and potential diagnostic biomarkers for human cancers. Theranostics. 7:3106–3117. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hu ZQ, Zhou SL, Li J, Zhou ZJ, Wang PC, Xin HY, Mao L, Luo CB, Yu SY, Huang XW, et al: Circular RNA sequencing identifies CircASAP1 as a key regulator in hepatocellular carcinoma metastasis. Hepatology. 72:906–922. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Siegel RL, Miller KD and Jemal A: Cancer statistics, 2018. CA Cancer J. Clin. 68:7–30. 2018.
|
|
39
|
Bagcchi S: Lung cancer survival only increases by a small amount despite recent treatment advances. Lancet Respir Med. 5:1692017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Jin X, Guan Y, Sheng H and Liu Y: Crosstalk in competing endogenous RNA network reveals the complex molecular mechanism underlying lung cancer. Oncotarget. 8:91270–91280. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhang C, Ma L, Niu Y, Wang Z, Xu X, Li Y and Yu Y: Circular RNA in lung cancer research: Biogenesis, functions, and roles. Int J Biol Sci. 16:803–814. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Qiu BQ, Zhang PF, Xiong D, Xu JJ, Long X, Zhu SQ, Ye XD, Wu Y, Pei X, Zhang XM and Wu YB: CircRNA fibroblast growth factor receptor 3 promotes tumor progression in non-small cell lung cancer by regulating galectin-1-AKT/ERK1/2 signaling. J Cell Physiol. 234:11256–11264. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhang S, Liu J, Yuan T, Liu H, Wan C and Le Y: Circular RNA 0001313 knockdown suppresses non-small cell lung cancer cell proliferation and invasion via the microRNA-452/HMGB3/ERK/MAPK axis. Int J Gen Med. 13:1495–1507. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Hu J, Li H, Wu C, Zhao X and Liu C: The prognostic value of decreased KLF4 in digestive system cancers: A meta-analysis from 17 studies. Dis Markers. 2017:30642462017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Sun C, Li G and Liu M: A novel circular RNA, circ_0005394, predicts unfavorable prognosis and contributes to hepatocellular carcinoma progression by regulating miR-507/E2F3 and miR-515-5p/CXCL6 signaling pathways. Onco Targets Ther. 13:6171–6180. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Llovet JM and Bruix J: Molecular targeted therapies in hepatocellular carcinoma. Hepatology. 48:1312–1327. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Zhang X, Wang X, Wu T, Li B, Liu T, Wang R, Liu Q, Liu Z, Gong Y and Shao C: Isoliensinine induces apoptosis in triple-negative human breast cancer cells through ROS generation and p38 MAPK/JNK activation. Sci Rep. 5:125792015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zou P, Zhang J, Xia Y, Kanchana K, Guo G, Chen W, Huang Y, Wang Z, Yang S and Liang G: ROS generation mediates the anti-cancer effects of WZ35 via activating JNK and ER stress apoptotic pathways in gastric cancer. Oncotarget. 6:5860–5876. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Xu L, Feng X, Hao X, Wang P, Zhang Y, Zheng X, Li L, Ren S, Zhang M and Xu M: CircSETD3 (Hsa_circ_0000567) acts as a sponge for microRNA-421 inhibiting hepatocellular carcinoma growth. J Exp Clin Cancer Res. 38:982019. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Li W, Zhou X, Wu X, Wei J and Huang Z: The role of circular RNA hsa_circ_0085616 in proliferation and migration of hepatocellular carcinoma cells. Cancer Manag Res. 11:7369–7376. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Zhan W, Liao X, Chen Z, Li L, Tian T, Yu L, Wang W and Hu Q: Circular RNA hsa_circRNA_103809 promoted hepatocellular carcinoma development by regulating miR-377-3p/FGFR1/ERK axis. J Cell Physiol. 235:1733–1745. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Ahmad I, Iwata T and Leung HY: Mechanisms of FGFR-mediated carcinogenesis. Biochim Biophys Acta. 1823:850–860. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Qin M, Liu G, Huo X, Tao X, Sun X, Ge Z, Yang J, Fan J, Liu L and Qin W: Hsa_circ_0001649: A circular RNA and potential novel biomarker for hepatocellular carcinoma. Cancer Biomark. 16:161–169. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Xu Y, Yao Y, Zhong X, Leng K, Qin W, Qu L, Cui Y and Jiang X: Downregulated circular RNA hsa_circ_0001649 regulates proliferation, migration and invasion in cholangiocarcinoma cells. Biochem Biophys Res Commun. 496:455–461. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Li WH, Song YC, Zhang H, Zhou ZJ, Xie X, Zeng QN, Guo K, Wang T, Xia P and Chang DM: Decreased expression of Hsa_circ_00001649 in gastric cancer and its clinical significance. Dis Markers. 2017:45876982017. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Sun H, Wang Q, Yuan G, Quan J, Dong D, Lun Y and Sun B: Hsa_circ_0001649 restrains gastric carcinoma growth and metastasis by downregulation of miR-20a. J Clin Lab Anal. 34:e232352020. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Hsiao YC, Yeh MH, Chen YJ, Liu JF, Tang CH and Huang WC: Lapatinib increases motility of triple-negative breast cancer cells by decreasing miRNA-7 and inducing Raf-1/MAPK-dependent interleukin-6. Oncotarget. 6:37965–37978. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Weng W, Wei Q, Toden S, Yoshida K, Nagasaka T, Fujiwara T, Cai S, Qin H, Ma Y and Goel A: Circular RNA ciRS-7-A circular RNA ciRS-7-A promising prognostic biomarker and a potential therapeutic target in colorectal cancer. Clin Cancer Res. 23:3918–3928. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Pennathur A, Gibson MK, Jobe BA and Luketich JD: Oesophageal carcinoma. Lancet. 381:400–412. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Shi Y, Fang N, Li Y, Guo Z, Jiang W, He Y, Ma Z and Chen Y: Circular RNA LPAR3 sponges microRNA-198 to facilitate esophageal cancer migration, invasion, and metastasis. Cancer Sci. 111:2824–2836. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Gao L, Dou ZC, Ren WH, Li SM, Liang X and Zhi KQ: CircCDR1as upregulates autophagy under hypoxia to promote tumor cell survival via AKT/ERK½/mTOR signaling pathways in oral squamous cell carcinomas. Cell Death Dis. 10:7452019. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Deng W, Peng W, Wang T, Chen J, Qiu X, Fu L and Zhu S: Microarray profile of circular RNAs identifies hsa_circRNA_102459 and hsa_circRNA_043621 as important regulators in oral squamous cell carcinoma. Oncol Rep. 42:2738–2749. 2019.PubMed/NCBI
|
|
64
|
Li Z, Chen Z, Hu G and Jiang Y: Roles of circular RNA in breast cancer: Present and future. Am J Transl Res. 11:3945–3954. 2019.PubMed/NCBI
|
|
65
|
Gao D, Qi X, Zhang X, Fang K, Guo Z and Li L: hsa_circRNA_0006528 as a competing endogenous RNA promotes human breast cancer progression by sponging miR-7-5p and activating the MAPK/ERK signaling pathway. Mol Carcinog. 58:554–564. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Wu F and Zhou J: CircAGFG1 promotes cervical cancer progression via miR-370-3p/RAF1 signaling. BMC Cancer. 19:10672019. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Huang P, Qi B, Yao H, Zhang L, Li Y and Li Q: Circular RNA cSMARCA5 regulates the progression of cervical cancer by acting as a microRNA-432 sponge. Mol Med Rep. 21:1217–1223. 2020.PubMed/NCBI
|
|
68
|
Huang XB, Song KJ, Chen GB, Liu R, Jiang ZF and He YL: Circular RNA hsa_circ_0003204 promotes cervical cancer cell proliferation, migration, and invasion by regulating MAPK pathway. Cancer Biol Ther. 21:972–982. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
van Son M, Peters M, Moerland M, Kerkmeijer L, Lagendijk J and van der Voort van Zyp J: Focal salvage treatment of radiorecurrent prostate Cancer: Anarrative review of current strategies and future perspectives. Cancers (Basel). 10:4802018. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Yan Z, Xiao Y, Chen Y and Luo G: Screening and identification of epithelial-to-mesenchymal transition-related circRNA and miRNA in prostate cancer. Pathol Res Pract. 216:1527842020. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Si-Tu J, Cai Y, Feng T, Yang D, Yuan S, Yang X, He S, Li Z, Wang Y, Tang Y, et al: Upregulated circular RNA circ-102004 that promotes cell proliferation in prostate cancer. Int J Biol Macromol. 122:1235–1243. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Lenis AT, Lec PM, Chamie K and Mshs MD: Bladder cancer: A review. JAMA. 324:1980–1991. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A and Bray F: Bladder cancer incidence and mortality: A global overview and recent trends. Eur Urol. 71:96–108. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Sun M, Zhao W, Chen Z, Li M, Li S, Wu B and Bu R: Circular RNA CEP128 promotes bladder cancer progression by regulating Mir-145-5p/Myd88 via MAPK signaling pathway. Int J Cancer. 145:2170–2181. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Zhong Z, Huang M, Lv M, He Y, Duan C, Zhang L and Chen J: Circular RNA MYLK as a competing endogenous RNA promotes bladder cancer progression through modulating VEGFA/VEGFR2 signaling pathway. Cancer Lett. 403:305–317. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Lu HC, Yao JQ, Yang X, Han J, Wang JZ, Xu K, Zhou R, Yu H, Lv Q and Gu M: Identification of a potentially functional circRNA-miRNA-mRNA regulatory network for investigating pathogenesis and providing possible biomarkers of bladder cancer. Cancer Cell Int. 20:312020. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Li J, Huang C, Zou Y, Ye J, Yu J and Gui Y: CircTLK1 promotes the proliferation and metastasis of renal cell carcinoma by sponging miR-136-5p. Mol Cancer. 19:1032020. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Chen Q, Liu T, Bao Y, Zhao T, Wang J, Wang H, Wang A, Gan X, Wu Z and Wang L: CircRNA cRAPGEF5 inhibits the growth and metastasis of renal cell carcinoma via the miR-27a-3p/TXNIP pathway. Cancer Lett. 469:68–77. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Liu H, Bi J, Dong W, Yang M, Shi J, Jiang N, Lin T and Huang J: Invasion-related circular RNA circFNDC3B inhibits bladder cancer progression through the miR-1178-3p/G3BP2/SRC/FAK axis. Mole-cular Cancer. 17:1612018. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Chen T, Yu Q, Shao S and Guo L: Circular RNA circFNDC3B protects renal carcinoma by miR-99a downregulation. J Cell Physiol. 235:4399–4406. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Liu X, Zhou C, Li Y, Deng Y, Lu W and Li J: Upregulation of circ-0000745 in acute lymphoblastic leukemia enhanced cell proliferation by activating ERK pathway. Gene. 751:1447262020. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Zhou F, Wang D, Wei W, Chen H, Shi H, Zhou N, Wu L and Peng R: Comprehensive profiling of circular RNA expressions reveals potential diagnostic and prognostic biomarkers in multiple myeloma. BMC Cancer. 20:402020. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Zheng J, Liu X, Xue Y, Gong W, Ma J, Xi Z, Que Z and Liu Y: TTBK2 circular RNA promotes glioma malignancy by regulating miR-217/HNF1β/Derlin-1 pathway. J Hematol Oncol. 10:522017. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Gerecke C, Fuhrmann S, Strifler S, Schmidt-Hieber M, Einsele H and Knop S: The diagnosis and treatment of multiple myeloma. Dtsch Arztebl Int. 113:470–476. 2016.PubMed/NCBI
|
|
85
|
Brigle K and Rogers B: Pathobiology and diagnosis of multiple myeloma. Semin Oncol Nurs. 33:225–236. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Joshua DE, Bryant C, Dix C, Gibson J and Ho J: Biology and therapy of multiple myeloma. Med J Aust. 210:375–380. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Ring ES, Lawson MA, Snowden JA, Jolley I and Chantry AD: New agents in the treatment of myeloma bone disease. Calcif Tissue Int. 102:196–209. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Kim H, Zheng S, Amini SS, Virk SM, Mikkelsen T, Brat DJ, Grimsby J, Sougnez C, Muller F, Hu J, et al: Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution. Genome Res. 25:316–327. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
He J, Huang Z, He M, Liao J, Zhang Q, Wang S, Xie L, Ouyang L, Koeffler HP, Yin D and Liu A: Circular RNA MAPK4 (circ-MAPK4) inhibits cell apoptosis via MAPK signaling pathway by sponging miR-125a-3p in gliomas. Mol Cancer. 19:172020. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Ko B, He T, Gadgeel S and Halmos B: MET/HGF pathway activation as a paradigm of resistance to targeted therapies. Ann Transl Med. 5:42017. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Pozzi C, Cuomo A, Spadoni I, Magni E, Silvola A, Conte A, Sigismund S, Ravenda PS, Bonaldi T, Zampino MG, et al: The EGFR-specific antibody cetuximab combined with chemotherapy triggers immunogenic cell death. Nat Med. 22:624–631. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Jeyaraman S, Hanif EAM, Ab Mutalib NS, Jamal R and Abu N: Circular RNAs: Potential regulators of treatment resistance in human cancers. Front Genet. 10:13692020. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Neuzillet C, Tijeras-Raballand A, de Mestier L, Cros J, Faivre S and Raymond E: MEK in cancer and cancer therapy. Pharmacol Ther. 141:160–171. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Li M, Meng F and Lu Q: expression profile screening and bioinformatics analysis of circRNA, LncRNA, and mRNA in acute myeloid leukemia drug-resistant cells. Turk J Haematol. 37:104–110. 2020.PubMed/NCBI
|
|
95
|
Salzman J, Chen RE, Olsen MN, Wang PL and Brown PO: Cell-type specific features of circular RNA expression. PLoS Genet. 9:e10037772013. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Böhmdorfer G and Wierzbicki AT: Control of chromatin structure by long noncoding RNA. Trends Cell Biol. 25:623–632. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Du WW, Yang W, Liu E, Yang Z, Dhaliwal P and Yang BB: Foxo3 circular RNA retards cell cycle progression via forming ternary complexes with p21 and CDK2. Nucleic Acids Res. 44:2846–2858. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Holdt LM, Stahringer A, Sass K, Pichler G, Kulak NA, Wilfert W, Kohlmaier A, Herbst A, Northoff BH, Nicolaou A, et al: Circular non-coding RNA ANRIL modulates ribosomal RNA maturation and atherosclerosis in humans. Nat Commun. 7:124292016. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Yaeger R and Corcoran RB: Targeting alterations in the RAF-MEK pathway. Cancer Discov. 9:329–341. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
McCubrey JA, Rakus D, Gizak A, Steelman LS, Abrams SL, Lertpiriyapong K, Fitzgerald TL, Yang LV, Montalto G, Cervello M, et al: Effects of mutations in Wnt/β-catenin, hedgehog, notch and PI3K pathways on GSK-3 activity-diverse effects on cell growth, metabolism and cancer. Biochim Biophys Acta. 1863:2942–2976. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Wu C, Zhuang Y, Jiang S, Liu S, Zhou J, Wu J, Teng Y, Xia B, Wang R and Zou X: Interaction between Wnt/β-catenin pathway and microRNAs regulates epithelial-mesenchymal transition in gastric cancer (Review). Int J Oncol. 48:2236–2246. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Guo YH, Wang LQ, Li B, Xu H, Yang JH, Zheng LS, Yu P, Zhou AD, Zhang Y, Xie SJ, et al: Wnt/β-catenin pathway transactivates microRNA-150 that promotes EMT of colorectal cancer cells by suppressing CREB signaling. Oncotarget. 7:42513–42526. 2016. View Article : Google Scholar : PubMed/NCBI
|
